Skip to main content

Girl, 8, declared 'cancer free' thanks to groundbreaking experimental Stem Cell treatment

hen Ava Christianson was diagnosed with cancer at the age of four, doctors said she had the best odds.

She had the most common type of leukemia, acute lymphoblastic leukemia (ALL). In 90 per cent of cases, a conventional course of chemotherapy does the trick.

But her experience was different.

By the age of eight, Wisconsin-born Ava had tried all of the standard therapies - from chemo to a bone marrow transplant - and relapsed five times.

However, since she was first diagnosed researchers have made astonishing strides in the field of immunotherapy, training patients' bodies to fight their tumors.

It is a groundbreaking approach that offers new hope to patients with no options left.

This year Ava became the 18th person in history to try the new five-minute operation at the National Institutes of Health's Clinical Center.

In August, doctors gave her the all-clear.

Having been disappointed time and time again, her parents Bethany and Jay are reluctant to celebrate, but they told the Washington Post they are quietly hopeful. 

'We just need this to work and to stay working,' Bethany said. 

The new procedure - CAR T-Cell therapy - has never been tried in humans before this experiment. 

CAR T-Cell therapy is where about 30 million immune cells are taken out of the body, genetically modified using stem cells, and injected back in.

The modified cells are designed to hunt and kill the disease. 

Ava already tried the first version of CAR T-Cell therapy in Minnesota last year, relapsing soon after. 

This year she tried a new version developed by NIH. 

It is the most promising approach to fighting cancer to date, according to the expert panel of cancer researchers that Vice President Joe Biden recruited to fight cancer.

And doctors hope it could provide the key to combating leukemia, which is increasingly intelligent.  

Acute lymphoblastic leukaemia (ALL) is a cancer of the white blood cells, which are made in the bone marrow.

There are two different types of white blood cells - lymphocytes and myeloid cells- and they work together to fight infection.

Normally, white blood cells develop, repair and reproduce in an orderly and controlled way.

But in leukaemia, the process gets out of control and the cells continue to divide in the bone marrow, but do not mature.

These immature dividing cells fill up the bone marrow and stop it from making healthy blood cells.

As the leukemia cells fail to mature, they cannot work properly to fight infections, leading to an increased risk of infection.

Because the bone marrow cannot make enough healthy red blood cells and platelets, symptoms such as anemia and bruising can occur.

Chronic forms of the disease tend to affect adults and are very rare in children. 

Normally, children with ALL respond quickly to a bone marrow transplant.

Until recently, there was no other option.

'Five years ago our doctor would have just had to tell us to go home,' Bethany told the Post. 

Now they are home in Prescott, Wisconsin, hoping to let Ava get on with a normal childhood.  

But the number of set-backs they've had make it hard to believe this is it. 

When it all started, their doctors said 90 per cent of children will never relapse in the rest of their lives after traditional treatment.  

'Ninety per cent, you feel pretty darn good that you're ok,' Bethany told the Post. 

'And then when we found out that she'd relapsed we were still told with bone marrow transplant that it was like 80-85 per cent chance that this was going to cure her.

'So you still... you get this... "ok we just need to get through this and we'll be ok". 

'That's been the most frustrating thing, you stop paying attention to the probabilities.'

Jay added: 'It gets to a point where you're like... "we need to figure this out" and you just keep searching and doing. Luckily we've been led here and hopefully this is our last stop for her and it fixes it.'

Source : https://goo.gl/cmByDZ

Comments

Popular posts from this blog

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age   The field of regenerative medicine reached a remarkable milestone recently when four women regained full sexual function after the successful implantation of lab-grown vaginas created from their own cells. The women, aged thirteen to eighteen, were born with a rare medical condition called Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS) which left them with an abnormal or missing vagina. Each woman underwent a newly engineered procedure that involved taking samples of the patient's own cells and growing them into tissue. This tissue was then placed on a scaffold that was hand-sewn with collagen-like fibers and uniquely shaped to fit each woman’s vaginal cavity. Once the organ fully matured, it was implanted into a canal in each woman’s pelvis, along with the hand-sewn scaffolding. Within six months, the biodegradable scaffolding dissolved and, in each of the four women, the lab-grown vaginas began fun...

Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS

 Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS At least 40 cases of mucormycosis, also known as black fungus, have been reported from Surat in Gujarat among those who have recovered from Covid-19. Of the 40, eight have lost their eyesight. What is this infection and who is more vulnerable? Cases of mucormycosis, commonly known as black fungus, have been reported from Gujarat among those who have recovered from Covid-19. The number of such cases has increased as Gujarat sees an exponential rise in coronavirus infections. At least eight persons were reported to have lost their eyesight in Surat due to mucormycosis (MM) after recovering from Covid-19. They had to be admitted to hospitals for the sudden loss of vision. In the past 15 days, Surat has reported at least 40 cases of mucormycosis or black fungus including eight who have lost their eyesight. The infection, triggered by Covid-19, is treatable but if left untreated or if the treatment is ...

US Moves to Shut Down 2 Big Stem Cell Therapy Clinics

Federal authorities Wednesday moved to shut down two of the country’s most prominent for-profit providers of stem cell therapy, one of them a network of clinics with more than 100 offices in the United States, including several in the Bay Area. The Food and Drug Administration filed two complaints in federal court requesting permanent injunctions that would stop Florida-based U.S. Stem Cell Clinic and the California Stem Cell Treatment Center from marketing therapies. Both companies have previously been called out by the FDA for providing unproven, unapproved therapies that could put patients at risk. The injunction requests are an aggressive move by the FDA to patrol the consumer stem cell market. The agency has come under mounting pressure by scientists and patient advocates to increase oversight of the growing consumer market, which has been allowed to flourish for years. “In the two cases filed today, the clinics and their leadership have continued to disregard th...